Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities.
[22q11.2 deletion syndrome]
The
22
q
11
.
2
deletion
syndrome
(
22
q
11
DS
)
presents
with
medical
and
neuropsychiatric
manifestations
including
neurocognitive
deficits
.
Quantitative
neurobehavioral
measures
linked
to
brain
circuitry
can
help
elucidate
genetic
mechanisms
contributing
to
deficits
.
To
establish
the
neurocognitive
profile
and
neurocognitive
'
growth
charts
'
,
we
compared
cross-sectionally
137
individuals
with
22
q
11
DS
ages
8
-
21
to
439
demographically
matched
non-deleted
individuals
with
developmental
delay
(
DD
)
and
medical
comorbidities
and
443
typically
developing
(
TD
)
participants
.
We
administered
a
computerized
neurocognitive
battery
that
measures
performance
accuracy
and
speed
in
executive
,
episodic
memory
,
complex
cognition
,
social
cognition
and
sensorimotor
domains
.
The
accuracy
performance
profile
of
22
q
11
DS
showed
greater
impairment
than
DD
,
who
were
impaired
relative
to
TD
.
Deficits
in
22
q
11
DS
were
most
pronounced
for
face
memory
and
social
cognition
,
followed
by
complex
cognition
.
Performance
speed
was
similar
for
22
q
11
DS
and
DD
,
but
22
q
11
DS
individuals
were
differentially
slower
in
face
memory
and
emotion
identification
.
The
growth
chart
,
comparing
neurocognitive
age
based
on
performance
relative
to
chronological
age
,
indicated
that
22
q
11
DS
participants
lagged
behind
both
groups
from
the
earliest
age
assessed
.
The
lag
ranged
from
less
than
1
year
to
over
3
years
depending
on
chronological
age
and
neurocognitive
domain
.
The
greatest
developmental
lag
across
the
age
range
was
for
social
cognition
and
complex
cognition
,
with
the
smallest
for
episodic
memory
and
sensorimotor
speed
,
where
lags
were
similar
to
DD
.
The
results
suggest
that
22
q
11
.
2
microdeletion
confers
specific
vulnerability
that
may
underlie
brain
circuitry
associated
with
deficits
in
several
neuropsychiatric
disorders
,
and
therefore
help
identify
potential
targets
and
developmental
epochs
optimal
for
intervention
.
Diseases
Validation
Diseases presenting
"and therefore help identify potential targets and developmental epochs optimal for intervention"
symptom
22q11.2 deletion syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom